Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (7)
Nature (3)
Scientific Reports (2)
Oncogene (1)
British Journal of Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (13)
Comments & Opinion (4)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biotechnology
Cancer
Cell biology
Diseases
Genetics
Health care
Molecular biology
Optics and photonics
Physics
Plant sciences

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–18 of 18 results

Advanced filters: Author: T Lahaye Clear advanced filters

HIV-specific cytotoxic T lymphocytes in seropositive individuals

Bruce D. Walker
Sekhar Chakrabarti
Robert T. Schooley
Research23 Jul 1987
Nature

Volume: 328, P: 345-348
DNA methylation protects cancer cells against senescence

Using degron approaches, the authors show that cancer cells experiencing prolonged DNA methylation loss—without substantial DNA damage—undergo non-canonical senescence. This has important potential implications for cancer treatment.

Xiaoying Chen
Kosuke Yamaguchi
Pierre-Antoine Defossez
ResearchOpen Access01 Jul 2025
Nature Communications

Volume: 16, P: 1-22
A new superfamily of replicative proteins

T. C. HODGMAN
Research05 May 1988
Nature

Volume: 333, P: 22-23
Stabilization of a purely dipolar quantum gas against collapse

For the first time, a purely dipolar quantum gas has been prepared experimentally. Different regimes have been explored; in some, the gas is stable, whereas in others it collapses due to the strong dipole–dipole interaction between the constituent atoms.

T. Koch
T. Lahaye
T. Pfau
Research24 Feb 2008
Nature Physics

Volume: 4, P: 218-222
Ultrafast energy exchange between two single Rydberg atoms on a nanosecond timescale

An array of ⁸⁷Rb atoms with inter-atomic distances of 1.5 μm is prepared by holographic optical tweezers. When a pair of nearby ⁸⁷Rb atoms is optically excited to a Rydberg state, the energy exchange between the atoms is observed on a timescale of nanoseconds.

Y. Chew
T. Tomita
K. Ohmori
ResearchOpen Access08 Aug 2022
Nature Photonics

Volume: 16, P: 724-729
Strong dipolar effects in a quantum ferrofluid

This paper reports the realization of a chromium Bose-Einstein condensate (BEC) with strong anisotropic magnetic dipole–dipole interaction between the atoms, which induces a pronounced change of the aspect ratio of the cloud. The experiment opens the way for exploration of the unique properties of quantum ferrofluids.

Thierry Lahaye
Tobias Koch
Tilman Pfau
Research09 Aug 2007
Nature

Volume: 448, P: 672-675
Comparative analysis of proximate compositions, mineral and functional chemical groups of 15 different seaweed species

Amal D. Premarathna
Rando Tuvikene
R. P. V. J. Rajapakse
ResearchOpen Access15 Nov 2022
Scientific Reports

Volume: 12, P: 1-13
Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity

Maja G. Rydahl
Stjepan K. Kračun
William G. T. Willats
ResearchOpen Access24 Aug 2017
Scientific Reports

Volume: 7, P: 1-13
Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography

T D Reid
D S Y Chan
W G Lewis
ResearchOpen Access20 Nov 2012
British Journal of Cancer

Volume: 107, P: 1925-1931
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies

U Berger
O Maywald
R Hehlmann
Research14 Apr 2005
Leukemia

Volume: 19, P: 984-989
Range-wide patterns of nuclear and chloroplast DNA diversity in Vriesea gigantea (Bromeliaceae), a neotropical forest species

C Palma-Silva
C Lexer
M H Bodanese-Zanettini
Research09 Sept 2009
Heredity

Volume: 103, P: 503-512
The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro

N von Bubnoff
S P Gorantla
J Duyster
Research25 Oct 2010
Oncogene

Volume: 30, P: 933-943
Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization

MC Müller
K Merx
A Hochhaus
Research26 Nov 2002
Leukemia

Volume: 16, P: 2395-2399
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

A Hochhaus
S Kreil
R Hehlmann
Comments & Opinion28 Oct 2002
Leukemia

Volume: 16, P: 2190-2196
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

K Merx
MC Müller
A Hochhaus
Comments & Opinion30 Aug 2002
Leukemia

Volume: 16, P: 1579-1583
Molecular monitoring of response to imatinib (Glivec^®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission

P Paschka
M C Müller
A Hochhaus
Comments & Opinion10 Sept 2003
Leukemia

Volume: 17, P: 1687-1694
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

M Rohrbacher
U Berger
R Hehlmann
Correspondence11 Sept 2008
Leukemia

Volume: 23, P: 602-604
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

M C Müller
N Gattermann
A Hochhaus
Comments & Opinion02 Oct 2003
Leukemia

Volume: 17, P: 2392-2400